PMID

Data

Article Title

Organization

Inhibitor screening and enzymatic activity determination for autophagy target Atg4B using a gel electrophoresis-based assay.

University of Antwerp

Extended structure-activity relationship and pharmacokinetic investigation of (4-quinolinoyl)glycyl-2-cyanopyrrolidine inhibitors of fibroblast activation protein (FAP).

University of Antwerp

Isoneocryptolepine, a synthetic indoloquinoline alkaloid, as an antiplasmodial lead compound.

University of Antwerp

P2-substituted N-acylprolylpyrrolidine inhibitors of prolyl oligopeptidase: biochemical evaluation, binding mode determination, and assessment in a cellular model of synucleinopathy.

University of Antwerp

Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers.

University of Antwerp

Synthesis and biochemical evaluation of guanidino-alkyl-ribitol derivatives as nucleoside hydrolase inhibitors.

University of Antwerp

Small, potent, and selective diaryl phosphonate inhibitors for urokinase-type plasminogen activator with in vivo antimetastatic properties.

University of Antwerp

1,2,3-Triazolylalkylribitol derivatives as nucleoside hydrolase inhibitors.

University of Antwerp

Synthesis and evaluation of non-basic inhibitors of urokinase-type plasminogen activator (uPA).

University of Antwerp

Design and evaluation of Trypanosoma brucei metacaspase inhibitors.

University of Antwerp

Adenosine-1 active ligands: cirsimarin, a flavone glycoside from Microtea debilis.

University of Antwerp

Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9. Part 1: identification of dipeptide derived leads.

University of Antwerp

Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9. Part 2: isoindoline containing inhibitors.

University of Antwerp

Irreversible inhibition of dipeptidyl peptidase 8 by dipeptide-derived diaryl phosphonates.

University of Antwerp

Highly Selective Inhibitors of Dipeptidyl Peptidase 9 (DPP9) Derived from the Clinically Used DPP4-Inhibitor Vildagliptin.

University of Antwerp

Diphenyl phosphonate inhibitors for the urokinase-type plasminogen activator: optimization of the P4 position.

University of Antwerp

Gamma-amino-substituted analogues of 1-[(S)-2,4-diaminobutanoyl]piperidine as highly potent and selective dipeptidyl peptidase II inhibitors.

University of Antwerp

Development of irreversible diphenyl phosphonate inhibitors for urokinase plasminogen activator.

University of Antwerp

Prolylisoxazoles: potent inhibitors of prolyloligopeptidase with antitrypanosomal activity.

University of Antwerp

Synthesis and biological evaluation of dihydrobenzofuran lignans and related compounds as potential antitumor agents that inhibit tubulin polymerization.

University of Antwerp

Optimization of Hydantoins as Potent Antimycobacterial Decaprenylphosphoryl-β-d-Ribose Oxidase (DprE1) Inhibitors.

University of Antwerp

Lead Optimization of Phthalazinone Phosphodiesterase Inhibitors as Novel Antitrypanosomal Compounds.

University of Antwerp

Identification and Profiling of Hydantoins-A Novel Class of Potent Antimycobacterial DprE1 Inhibitors.

University of Antwerp

α-Amino Diphenyl Phosphonates as Novel Inhibitors of Escherichia coli ClpP Protease.

University of Antwerp

Novel diarylpyridinones, diarylpyridazinones and diarylphthalazinones as potential HIV-1 nonnucleoside reverse transcriptase inhibitors (NNRTIs).

University of Antwerp

Tozasertib Analogues as Inhibitors of Necroptotic Cell Death.

University of Antwerp

Synthesis and tyrosine kinase inhibitory activity of a series of 2-amino-8H-pyrido[2,3-d]pyrimidines: identification of potent, selective platelet-derived growth factor receptor tyrosine kinase inhibitors.

Parke-Davis Pharmaceutical Research